Pakuwon Jati Tbk (PWON)
Jakarta Exchange · Indonesia · prices in IDR · close of 23 Oct 2026
Key indicators
| Last close | IDR 282.00 |
|---|---|
| 52-week range | 236.00 – 440.00 |
| Return, 1 month / 3 months | +1.4% / +2.9% |
| Return, 1 year / 3 years | −20.0% / −20.6% |
| Trend | Below its 200-day average |
| RSI (14) | 56 |
| Volatility (1 year) | 33.8% |
| Worst drawdown (1 year) | -37.6% |
| Average daily value traded | 13,310.21M IDR |
| Dividend yield | 4.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Pakuwon Jati is an Indonesian property company based in Surabaya. It develops and operates shopping malls, and it also builds residential and commercial properties, including condominiums, office space and mixed-use superblocks. Its customers are shoppers, retailers, home buyers and businesses in Indonesia's main cities, and its malls and developments are concentrated in Jakarta and Surabaya. The company manages its investment properties and sells residential units to the public.
On this site Pakuwon Jati Tbk appears as a stock on the Jakarta Exchange (Indonesia), code PWON, with prices in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Pakuwon Jati Tbk (PWON) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 282.00 on 23 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 209 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.0% and over the last three months it rose 2.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -3.4% | ||
| From 52-week high | -27.3% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 2.9% | ||
| 6-month return | -13.5% | ||
| 12-month return, skipping the last month | -21.1% | ||
| Stability (higher is calmer) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.6% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 13,310.21M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 65 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.6% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +6.8% |
|---|---|
| 1 month | +1.4% |
| 3 months | +2.9% |
| 6 months | −13.5% |
| 1 year | −20.0% |
| 3 years | −20.6% |
| 5 years | −38.5% |
Signals
| 50-day / 200-day average | 269.52 / 292.04 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 11.75 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Jun 2026 | IDR 13.0000 |
| 7 Jul 2025 | IDR 13.0000 |
| 25 Jun 2024 | IDR 9.0000 |
| 11 Jul 2023 | IDR 6.5000 |
| 14 Jul 2022 | IDR 4.0000 |
| 4 Jul 2019 | IDR 7.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.